SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-23-047712
Filing Date
2023-09-12
Accepted
2023-09-12 16:07:40
Documents
1
Period of Report
2023-09-12

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3404
  Complete submission text file 0000950170-23-047712.txt   4780
Mailing Address C/O PRAECIS PHARMACEUTICALS INC 830 WINTER STREET WALTHAM MA 02451
Business Address
BOHLIN GAREN G (Reporting) CIK: 0001254705 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 231250166

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations